←
Loading live data…
PRICE
Loading…
REVENUE MIX
Total Revenue100%
COST
COGS24%
R&D + SG&A27%
Op Margin49%
FINANCIAL HEALTH
REVENUE
$75.5B
Growth
48%
Gross M.
76%
P/E
63.3
EV/EBITDA
42.1
Net M.
39%
FCF M.
36%
D/E
0.8
Op M.
49%
PLUG INTO YOUR DCF
Historical growth
21.7%
Analyst 5y growth
—
Forward P/E
18.6
PEG ratio
0.40
Trailing EPS
$5.70
Forward EPS
$19.50
🚩 RED FLAG SCANNER — 10-K RISK FACTORS, YEAR OVER YEAR
TAM
SIZE
—
CAGR
—
Market-size estimates aren't available for this stock right now — see Financial Health and Risk Assessment below for a fundamentals-based read instead.
RISK ASSESSMENT
LOWA mechanical base-case DCF (default assumptions) implies 23% upside to $446.31 — take this as a rough, unverified estimate, not a target.
LOWDebt/equity of 0.80 — conservative balance sheet.
MEDRevenue growing 48% YoY — the multiple depends on this pace continuing; deceleration is a real risk.
🐂 BULL
AVGO shows revenue grew +47.9% YoY, 49% operating margin, 37% ROE, a healthy 36% free cash flow margin — a business converting growth into real profit.
🐻 BEAR
At a P/E of 63.3 and EV/EBITDA of 42.1, the stock is priced for continued execution — any deceleration in growth or margin compression would likely pressure the multiple.
AI-powered data, computed by TreasureX · May contain inaccuracies
⚠️
All values, scores, and figures here are computed from your own assumptions and public data, for educational purposes only. This is not investment advice — TreasureX does not recommend buying or selling any security. Results change with your inputs. Please do your own research and use your own judgement before making any investment decision.